Colloidal Oatmeal Cream

Phase 3Completed

0 views this week 0 watching⚡ Active

Interest: 40/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Eczema

Conditions

Eczema

Trial Timeline

Mar 1, 2014 → Nov 1, 2014

NCT ID

NCT02120833

About Colloidal Oatmeal Cream

Colloidal Oatmeal Cream is a phase 3 stage product being developed by Johnson & Johnson for Eczema. The current trial status is completed. This product is registered under clinical trial identifier NCT02120833. Target conditions include Eczema.

What happened to similar drugs?

2 of 12 similar drugs in Eczema were approved

Approved (2) Terminated (2) Active (8)

✅Pimecrolimus cream 1%NovartisApproved

✅DupilumabRegeneron PharmaceuticalsApproved

🔄AbrocitinibPfizerPhase 3

🔄alitretinoin + PlaceboGSK plcPhase 3

❌Ruxolitinib cream + VehicleIncytePhase 3

🔄ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%Arcutis BiotherapeuticsPhase 3

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT02120833	Phase 3	Completed	Mar 1, 2014	Nov 1, 2014	Eczema

Competing Products

20 competing products in Eczema

See all competitors

Product	Company	Stage	Hype Score
1% Colloidal Oatmeal Balm	Johnson & Johnson	Pre-clinical	18
Pimecrolimus cream 1%	Novartis	Approved	43
Abrocitinib	Pfizer	Phase 3	47
Dupilumab + Placebo	Sanofi	Phase 2	31
Amlitelimab + Placebo	Sanofi	Phase 2	35
alitretinoin + Placebo	GSK plc	Phase 3	40
Dupilumab	Regeneron Pharmaceuticals	Approved	39
Adventan® (methylprednisolone aceponate 0,1%)	Bayer	Phase 1	26
Ruxolitinib cream + Vehicle	Incyte	Phase 3	29
Ruxolitinib cream + Vehicle	Incyte	Phase 2	32
Ruxolitinib cream + Vehicle	Incyte	Phase 3	29
ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%	Arcutis Biotherapeutics	Phase 3	34
Roflumilast Cream + Vehicle cream	Arcutis Biotherapeutics	Phase 3	34
ARQ-151 cream 0.05%	Arcutis Biotherapeutics	Phase 2	29
Roflumilast Cream 0.05% + Vehicle Cream	Arcutis Biotherapeutics	Phase 3	34
Roflumilast Cream 0.15% + Vehicle Cream	Arcutis Biotherapeutics	Phase 3	34
ARQ-151 cream 0.15% + ARQ-151 cream 0.05%	Arcutis Biotherapeutics	Phase 1	23
ARQ-252 cream 0.3% + ARQ-252 cream 0.1% + ARQ-252 Vehicle Cream	Arcutis Biotherapeutics	Phase 1/2	26
LAS41003 + LAS189962 + LAS189961	Almirall	Phase 2	29
LAS 41002 + Active	Almirall	Phase 2	29